Breaking News
FDA moves to fast-track review of psychedelic drugs psilocybin and methylone for mental health following Trump executive order
FDA moves to fast-track review of psilocybin and methylone for mental health
Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental health treatments in the United States.


